{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/724-US10,975,364(Active) re (Done on website already).pdf"}, "page_content": "a nuclear localization sequence , a cell penetrating peptide\n\nID NO : 3 , SEQ ID NO : 4 or a homologue thereof having at\n\nsequence , an affinity tag or a fusion base editor protein ,\n\nleast 90 % overall sequence identity to the amino acid\n\nwherein the modified protein comprises the amino acid\n\nsequence .\n\nsequence selected from SEQ ID NO : 1 , SEQ ID NO : 2 , SEQ\n\n12. The method of claim 11 , wherein the modified protein\n\nID NO : 3 , SEQ ID NO : 4 or a homologue thereof having at 35 is expressed in the cell or the cell is contacted with the\n\nleast 90 % overall sequence identity to the amino acid\n\nmodified protein and a guide RNA having a region comple\n\nmentary to a selected portion of the genome of the cell .\n\nsequence .\n\n2. The modified protein of claim 1 , wherein the modified\n\n13. The method of claim 11 , wherein the modified protein\n\nprotein comprises the amino acid sequence of SEQ ID NO :\n\ncomprises the amino acid sequence of SEQ ID NO : 1 .\n\n14. The method of claim 11 , wherein the modified protein\n\n1 .\n\n40\n\n3. The modified protein of claim 1 , wherein the modified\n\ncomprises the amino acid sequence of SEQ ID NO : 2 .\n\nprotein comprises the amino acid sequence of SEQ ID NO :\n\n15. The method of claim 11 , wherein the modified protein\n\nfurther comprises one or more mutations at R245 , N419 or\n\n2 .\n\n4. The modified protein of claim 1 , further comprising one\n\nR654 positions .\n\nor more mutations at R245 , N419 or R654 positions .\n\n16. The method of claim 11 , wherein the modified protein\n\n45\n\n5. The modified protein of claim 1 , wherein the modified\n\ncomprises an amino acid sequence of SEQ ID NO : 3 .\n\nprotein comprises the amino acid sequence of SEQ ID NO :\n\n17. The method of claim 14 , wherein the modified protein\n\nfurther comprises one or more mutations at R245 , N419 and\n\n3 .\n\n6. The modified protein of claim 3 , further comprising\n\nR654 positions .\n\nmutations at R245 , N419 and R654 positions .\n\n18. The method of claim 11 , wherein the modified protein\n\n50", "type": "Document"}}